Arrowhead Pharmaceuticals... (ARWR)
12.77
-1.05 (-7.60%)
At close: Mar 31, 2025, 2:31 PM
Arrowhead Pharmaceuticals Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 |
| Revenue | 3.55M | 240.74M | 243.23M | 138.29M | 87.99M | 168.8M | 16.14M | 31.41M | 158.33K | 382K | 175K | 290.27K | 146.88K | 296.14K | 620.1K | 3.77M | 1.3M | 1.21M | 595.46K | 590.68K | 196.31K | n/a | 2.27K | 9.31K | 24.88K | 37K | 60.38K | 76.59K |
| Cost of Revenue | n/a | n/a | 10.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 724.09K | n/a | n/a | n/a | n/a | 87.00 | 6.3K | 2.09K | 2.85K | 33.78K | 36.97K |
| Gross Profit | 3.55M | 240.74M | 232.81M | 138.29M | 87.99M | 168.8M | 16.14M | 31.41M | 158.33K | 382K | 175K | 290.27K | 146.88K | 296.14K | 620.1K | 3.77M | 1.3M | 483.93K | 595.46K | 590.68K | 196.31K | n/a | 2.18K | 3.02K | 22.78K | 34.15K | 26.59K | 39.62K |
| Operating Income | -601.08M | -205M | -178.51M | -149.04M | -93.16M | 61.19M | -55.94M | -37M | -81.74M | -95.97M | -53.28M | -24.59M | -21.09M | -9.83M | -8.8M | -19.73M | -35M | -37.95M | -21.24M | -9.36M | -2.77M | -94.44K | -1.42M | -106.27K | -109.23K | -56.22K | -42.3K | -158.62K |
| Interest Income | 22.72M | 15.3M | 5.03M | 6.12M | 9.19M | 6.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.67K | 736.34M | n/a | n/a | 151.05K | 33.14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -612.46M | -206.49M | -172.71M | -140.85M | -84.55M | 68.15M | -54.45M | -34.38M | -81.72M | -91.94M | -58.72M | -31.7M | -22.11M | -8.79M | -7.34M | -19.16M | -35.12M | -37.95M | -21.92M | -6.99M | -2.5M | -94.44K | -246.21K | -185.82K | -137.55K | -368.46K | -10.54K | -854.53K |
| Net Income | -599.49M | -205.28M | -176.49M | -140.85M | -84.55M | 67.97M | -54.45M | -34.38M | -81.72M | -91.94M | -58.63M | -31.14M | -21.13M | -3.13M | -5.77M | -19.31M | -27.09M | -29.93M | -19M | -6.62M | -2.5M | -95.24K | -246.21K | -185.82K | -137.55K | 593K | -51.62K | -854.53K |
| Selling & General & Admin | 98.76M | 90.93M | 124.43M | 80.98M | 52.28M | 26.56M | 19.11M | 32.02M | 41M | 34.72M | 24.42M | 11.69M | 14.1M | 5.23M | 8M | 14.14M | 23.75M | 17.09M | 12.26M | 5.99M | 2.17M | 91.06K | 143.8K | 109.28K | 132.02K | 90.36K | 50.58K | 89.76K |
| Research & Development | 505.87M | 353.19M | 297.31M | 206.34M | 128.87M | 81.05M | 52.97M | 31.69M | 41.45M | 57.41M | 23.14M | 8.71M | 5.39M | 3.28M | 1.11M | 8.97M | 12.14M | 20.93M | 8.58M | 3.79M | 793.35K | 3.38K | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | 1.62M | 5.8M | 2.07M | -582.52K | n/a | 7.49K | 1.31M | 57.35K | 417.87K | 82.09K | -997.98K | 9.41B | 3.03B | 5.13B | 9.87B | 17.31B | 7.65B | 8.22B | 3.32M | 1.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 604.63M | 445.74M | 421.74M | 287.32M | 181.15M | 107.6M | 72.08M | 68.4M | 79.85M | 96.36M | 51.28M | 23.57M | 21.24M | 10.13M | 9.42M | 23.5M | 36.31M | 38.43M | 21.84M | 9.95M | 2.97M | 94.44K | 1.42M | 109.28K | 132.02K | 90.36K | 68.89K | 198.24K |
| Interest Expense | 32.35M | 18.33M | 5.03M | 6.12M | 9.19B | 6.96B | 1.05B | 415.13M | 265.79M | 729.16M | 645.49M | n/a | 35.97M | 86.53M | n/a | 150.89K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.82B | -4.37B | -5.02B | 3.32M | 1.26M | n/a | n/a | n/a | n/a | 34.18K | 38.13K | 78.48K |
| Cost & Expenses | 604.63M | 445.74M | 421.74M | 287.32M | 181.15M | 107.6M | 72.08M | 68.4M | 79.85M | 96.36M | 51.28M | 23.57M | 21.24M | 10.13M | 9.42M | 23.5M | 36.31M | 39.16M | 21.84M | 9.95M | 2.97M | 94.44K | 1.42M | 115.58K | 134.11K | 93.21K | 102.67K | 235.21K |
| Income Tax | -2.77M | 2.78M | 3.79M | 2K | 2.4K | 173.55K | 2.4K | 2.4K | 2.4K | 2.4K | 5.3K | 6.22M | -203.44K | -6.86M | -3.25M | 53.95K | -8.03M | -8.02M | -2.24M | -2.74M | 800.00 | 800.00 | -1.17M | 79.56K | 28.32K | -649.22K | 9.32K | 695.91K |
| Shares Outstanding (Basic) | 119.78M | 107.31M | 105.43M | 103.75M | 100.72M | 93.86M | 83.64M | 73.15M | 60.99M | 57.36M | 46.9M | 23.96M | 11.12M | 7.18M | 6.43M | 4.52M | 3.92M | 3.59M | 3.2M | 2.54M | 1.33M | 373.88K | 7.58K | 7.15K | 7.06K | 6.09K | 5.08K | 4.87K |
| Shares Outstanding (Diluted) | 119.78M | 106.75M | 105.43M | 103.75M | 100.72M | 98.61M | 83.64M | 73.9M | 61.05M | 57.36M | 46.93M | 24M | 11.13M | 7.18M | 6.43M | 4.52M | 3.92M | 3.59M | 3.2M | 2.54M | 1.33M | 373.88K | 7.58K | 7.15K | 7.06K | 6.09K | 5.08K | 4.87K |
| EPS (Basic) | -5 | -1.91 | -1.67 | -1.36 | -0.84 | 0.72 | -0.65 | -0.47 | -1.34 | -1.6 | -1.25 | -1.3 | -1.9 | -0.44 | -0.9 | -4.27 | -6.91 | -8.35 | -5.95 | -2.61 | -1.88 | -0.25 | -32.47 | -25.97 | -19.48 | 97.40 | -10.16 | -175.33 |
| EPS (Diluted) | -5 | -1.92 | -1.67 | -1.36 | -0.84 | 0.69 | -0.65 | -0.47 | -1.34 | -1.6 | -1.25 | -1.3 | -1.9 | -0.44 | -0.9 | -4.27 | -6.91 | -8.35 | -5.95 | -2.61 | -1.88 | -0.25 | -32.47 | -25.97 | -19.48 | 97.40 | -10.16 | -175.33 |
| EBITDA | -561.51M | -175.67M | -162.29M | -132.58M | -87.22M | 65.63M | -51.24M | -29.69M | -78.46M | -89.6M | -47.38M | -20.11M | -19.34M | -8.52M | -6.68M | -18.16M | -33.25M | -35.68M | -19.43M | -8.95M | -2.67M | -94.35K | -1.41M | -102.74K | -101.61K | -48.1K | -15.11K | -54.83K |
| Depreciation & Amortization | 18.59M | 12.49M | 10.42M | 8.27M | 5.94M | 4.44M | 4.7M | 4.69M | 3.26M | 2.34M | 1.35M | 1.75M | 1.75M | 267.98K | 654.69K | 994.6K | 1.13M | 1M | 886.96K | 644.01K | 74.74K | 90.00 | 9.08K | 3.53K | 7.62K | 8.12K | 18.31K | 103.79K |